View Item 

Show simple item record

Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages

dc.contributor.authorJagsi, Reshma
dc.contributor.authorSpence, Rebecca
dc.contributor.authorRathmell, W. Kimryn
dc.contributor.authorBradbury, Angela
dc.contributor.authorPeppercorn, Jeffrey
dc.contributor.authorGrubbs, Stephen
dc.contributor.authorMoy, Beverly
dc.date.accessioned2017-12-15T16:49:11Z
dc.date.available2017-12-15T16:49:11Z
dc.date.issued2014-02
dc.identifier.citationJagsi, Reshma; Spence, Rebecca; Rathmell, W. Kimryn; Bradbury, Angela; Peppercorn, Jeffrey; Grubbs, Stephen; Moy, Beverly (2014). "Ethical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages." The Oncologist 19(2): 186-192.
dc.identifier.issn1083-7159
dc.identifier.issn1549-490X
dc.identifier.urihttps://hdl.handle.net/2027.42/140043
dc.publisherAlphaMed Press
dc.publisherWiley Periodicals, Inc.
dc.subject.otherRecommendations
dc.subject.otherShortage
dc.subject.otherDrug
dc.subject.otherOncology
dc.subject.otherEthics
dc.subject.otherPolicy
dc.titleEthical Considerations for the Clinical Oncologist in an Era of Oncology Drug Shortages
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelHematology and Oncology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA;
dc.contributor.affiliationotherMassachusetts General Hospital, Boston, Massachusetts, USA
dc.contributor.affiliationotherMedical Oncology Hematology Consultants, Newark, Delaware, USA;
dc.contributor.affiliationotherDuke University, Durham, North Carolina, USA;
dc.contributor.affiliationotherUniversity of Pennsylvania, Philadelphia, Pennsylvania USA;
dc.contributor.affiliationotherUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA;
dc.contributor.affiliationotherAmerican Society of Clinical Oncology, Alexandria, Virginia, USA;
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/140043/1/onco0186.pdf
dc.identifier.doi10.1634/theoncologist.2013-0301
dc.identifier.sourceThe Oncologist
dc.identifier.citedreferenceR Jagsi, TF DeLaney, K Donelan. Real‐time rationing of scarce resources: The Northeast Proton Therapy Center experience. J Clin Oncol. 2004; 22: 2246 – 2250.
dc.identifier.citedreferenceS Hoffman. The drugs stop here: A public health framework to address the drug shortage crisis. Food Drug Law J. 2012; 67: 1 – 22.
dc.identifier.citedreferenceR Kaakeh, BV Sweet, C Reilly. Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm. 2011; 68: 1811 – 1819.
dc.identifier.citedreferenceA McBride, LM Holle, C Westendorf. National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm. 2013; 70: 609 – 617.
dc.identifier.citedreferenceK Haninger, A Jessup, K. Koehler. Economic analysis of the causes of drug shortages (ASPE issue brief). Washington, DC: United States Department of Health and Human Services. 2011, Available at http://www.aspe.hhs.gov/sp/reports/2011/drugshortages/ib.shtml.
dc.identifier.citedreferenceBA Chabner. Drug shortages—a critical challenge for the generic‐drug market. N Engl J Med. 2011; 365: 2147 – 2149.
dc.identifier.citedreferenceJacobson M, Alpert A, Duarte F. Prescription drug shortages: Reconsidering the role of Medicare payment policies. Available at http://healthaffairs.org/blog/2012/05/29/prescription‐drug‐shortages‐reconsidering‐the‐role‐of‐medicare‐payment‐policies.
dc.identifier.citedreferenceOffice of the Press Secretary. We can’t wait: Obama Administration takes action to reduce prescription drug shortages, fight price gouging [press release]. Washington, DC: White House. 2011, Available at http://www.whitehouse.gov/the‐press‐office/2011/10/31/we‐can‐t‐wait‐obama‐administration‐takes‐action‐reduce‐prescription‐drug.
dc.identifier.citedreferenceU.S. Food and Drug Administration. FDA acts to bolster supply of critically needed cancer drugs [press release], 02/2012 update. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm292658.htm.
dc.identifier.citedreferenceU.S. Food and Drug Administration. FDA approval of generic version of cancer drug Doxil is expected to help resolve shortage. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm337872.htm.
dc.identifier.citedreferenceU.S. Food and Drug Administration. The Food and Drug Administration Safety and Innovation Act (FDASIA), S. 3187, 2012. Available at http://www.gpo.gov/fdsys/pkg/BILLS‐112s3187pcs/pdf/BILLS‐112s3187pcs.pdf.
dc.identifier.citedreferenceD Callahan. Rationing: theory, politics, and passions. Hastings Cent Rep. 2011; 41: 23 – 27.
dc.identifier.citedreferenceHJ Aaron, WB Schwartz. The Painful Prescription: Rationing Hospital Care. Washington, DC: Brookings Institution. 1984.
dc.identifier.citedreferenceHJ Aaron, WB Schwartz. Can We Say NO? The Challenge of Rationing Health Care. Washington, DC: Brookings Institution. 2005.
dc.identifier.citedreferencePA Ubel. Pricing Life: Why It’s Time for Health Care Rationing. Cambridge, MA: MIT Press. 2000.
dc.identifier.citedreferenceA Boulis, S Goold, PA Ubel. Responding to the immunoglobulin shortage: A case study. J Health Polit Policy Law. 2002; 27: 977 – 999.
dc.identifier.citedreferenceHealth Resources and Services Administration. Organ distribution: Allocation of deceased kidneys, 9/12 update. Available at http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy_7.pdf.
dc.identifier.citedreferenceBH Scribner. Lasker Clinical Medicine Research Award. Medical dilemmas: The old is new. Nat Med. 2002; 8: 1066 – 1067.
dc.identifier.citedreferenceM Strosberg, J Wiener, R Baker, eds. Rationing America’s Medical Care: The Oregon Plan and Beyond. Washington, DC: Brookings Institution. 1992.
dc.identifier.citedreferenceG Calabresi, P Bobbitt. Tragic Choices. New York, NY: W.W. Norton. 1978.
dc.identifier.citedreferenceMG Bloche. Clinical loyalties and the social purposes of medicine. JAMA. 1999; 281: 268 – 274.
dc.identifier.citedreferencePA Ubel, RM Arnold. The unbearable rightness of bedside rationing. Physician duties in a climate of cost containment. Arch Intern Med. 1995; 155: 1837 – 1842.
dc.identifier.citedreferenceN Daniels, J Sabin. The ethics of accountability in managed care reform. Health Aff (Millwood). 1998; 17: 50 – 64.
dc.identifier.citedreferenceRosoff PM. Unpredictable drug shortages: An ethical framework for short‐term rationing in hospitals. Am J Bioeth. 2012; 12: 1 – 9.
dc.identifier.citedreferencePM Rosoff, KR Patel, A Scates. Coping with critical drug shortages: An ethical approach for allocating scarce resources in hospitals. Arch Intern Med. 2012; 172: 1494 – 1499.
dc.identifier.citedreferenceML Burda. Beyond the framework. Am J Bioeth. 2012; 12: 11 – 13.
dc.identifier.citedreferenceA Goodman. The tensions and challenges of unpredictable drug shortages. Am J Bioeth. 2012; 12: 20 – 22.
dc.identifier.citedreferenceR Bamford, CD Brewer, B Bucknell. A paradoxical ethical framework for unpredictable drug shortages. Am J Bioeth. 2012; 12: 16 – 18.
dc.identifier.citedreferenceJJ Caro, CN Coleman, A Knebel. Unaltered ethical standards for individual physicians in the face of drastically reduced resources resulting from an improvised nuclear device event. J Clin Ethics. 2011; 22: 33 – 41.
dc.identifier.citedreferenceAK Thompson, K Faith, JL Gibson. Pandemic influenza preparedness: An ethical framework to guide decision‐making. BMC Med Ethics. 2006; 7: E12.
dc.identifier.citedreferenceJL Gibson, S Bean, P Chidwick. Ethical framework for resource allocation during a drug supply shortage. Healthc Q. 2012; 15: 26 – 35.
dc.identifier.citedreferenceJ Peppercorn, A Armstrong, DW Zaas. Rationing in urologic oncology: Lessons from sipuleucel‐T for advanced prostate cancer. Urol Oncol. 2013; 31: 1079 – 1084.
dc.identifier.citedreferenceMP Link, K Hagerty, HM Kantarjian. Chemotherapy drug shortages in the United States: Genesis and potential solutions. J Clin Oncol. 2012; 30: 692 – 694.
dc.identifier.citedreferenceML Metzger, A Billett, MP Link. The impact of drug shortages on children with cancer—The example of mechlorethamine. N Engl J Med. 2012; 367: 2461 – 2463.
dc.identifier.citedreferenceJ Valgus, EA Singer, SR Berry. Ethical challenges: Managing oncology drug shortages. J Oncol Pract. 2013; 9: e21 – e23.
dc.identifier.citedreferenceE Blume. Investigators seek to increase taxol supply. J Natl Cancer Inst. 1989; 81: 1122 – 1123.
dc.identifier.citedreferenceN Landis. Provisional observations on drug product shortages: Effects, causes, and potential solutions. Am J Health Syst Pharm. 2002; 59: 2173 – 2182, Available at http://www.ashp.org/s_ashp/docs/files/DShort_11b‐SF‐Witmer.pdf.
dc.identifier.citedreferencePark A. Inside America’s drug shortage. Time, March 2012. Available at http://healthland.time.com/2012/03/19/where‐have‐all‐our‐drugs‐gone/.
dc.identifier.citedreferenceU.S. Food and Drug Administration, Center for Drugs and Evaluation Research Drug Shortage Program. Frequently asked questions about drug shortages. Available at http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050796.htm#q1.
dc.identifier.citedreferenceER Fox, A Birt, KB James, ASHP Expert Panel on Drug Product Shortages. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health Syst Pharm. 2009; 66: 1399 – 1406.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
onco0186.pdf
Size:
639.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.